Filter Results:
(2,164)
Show Results For
- All HBS Web
(3,524)
- People (9)
- News (719)
- Research (2,164)
- Events (38)
- Multimedia (28)
- Faculty Publications (1,287)
Show Results For
- All HBS Web
(3,524)
- People (9)
- News (719)
- Research (2,164)
- Events (38)
- Multimedia (28)
- Faculty Publications (1,287)
Sort by
- November 1983 (Revised December 1984)
- Case
Frito-Lay, Inc.: Grandma's ""Ready-To-Eat"" Cookies
Mr. Kenneth Treece, marketing director of Frito-Lay's Grandma's (R) Cookie division has received the final test market figures for the new supermarket line of Grandma's Ready-To-Eat cookies. One set of data, the Kansas City test results, was extremely encouraging;... View Details
Bonoma, Thomas V. Frito-Lay, Inc.: Grandma's ""Ready-To-Eat"" Cookies. Harvard Business School Case 584-043, November 1983. (Revised December 1984.)
- April 1973 (Revised April 1983)
- Case
Mirassou Vineyards (A)
Examines the decision by Mirassou to test a mechanical grape harvester that requires a major change in growing methods and operations. The machine is unproven and the investor has asked this vineyard to test it for him and commit to use it. View Details
Keywords: Technology; Organizational Change and Adaptation; Production; Agriculture and Agribusiness Industry
Wyckoff, Daryl D. "Mirassou Vineyards (A)." Harvard Business School Case 673-105, April 1973. (Revised April 1983.)
- October 1982 (Revised August 1999)
- Case
Johnson Wax: Enhance (A)
Johnson Wax has produced a new hair conditioner for problem hair. Before committing themselves to test market, they analyze the new product using a field based, pretest-market procedure called ASSESSOR. The testing reveals product positioning, advertising, and... View Details
Keywords: Product Positioning; Analysis; Marketing Communications; Advertising; Beauty and Cosmetics Industry
Clarke, Darral G. "Johnson Wax: Enhance (A)." Harvard Business School Case 583-046, October 1982. (Revised August 1999.)
- January 2001
- Case
Abgenix and the XenoMouse
By: Robert J. Dolan
Abgenix has a unique method for generating antibodies useful in treating a number of diseases, including cancer. In early 2000, the company's cancer has performed very well in animal testing and is moving to early stage human testing. Abgenix must decide whether to... View Details
Keywords: Product Development; Marketing Strategy; Health Testing and Trials; Risk and Uncertainty; Technological Innovation; Innovation Strategy; Science-Based Business; Biotechnology Industry
Dolan, Robert J. "Abgenix and the XenoMouse." Harvard Business School Case 501-061, January 2001.
- June 2016
- Teaching Plan
Terrapin Laboratory
By: Joseph B. Fuller and Andrew Otazo
This teaching plan accompanies the case "Terrapin Laboratory," HBS No. 315-098. That case describes the formation and rapid growth of a drug testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug... View Details
- October 1981 (Revised June 1985)
- Case
Vicks Health Care Division: Project Scorpio (B)
Reveals that Vicks chose a multi-condition positioning for the product. Describes testing of name and concept, and extensively reports on a four-city test market. Students are expected to evaluate both the design and results of the test, and face options ranging from... View Details
Yip, George S., and Jeffrey R Williams. "Vicks Health Care Division: Project Scorpio (B)." Harvard Business School Case 582-040, October 1981. (Revised June 1985.)
- 25 Mar 2021
- Research & Ideas
Steer Clear of the Blind Spots That Derail Experiments
says Luca, the Lee J. Styslinger III Associate Professor of Business Administration. “They can’t rely on data scientists alone.” Experiments have come to have an outsize influence within tech companies from Uber to Zillow, which test... View Details
Keywords: by Danielle Kost
- May 2013
- Teaching Note
Launching Krispy Natural: Cracking the Product Management Code (Brief Case)
By: Frank V. Cespedes and Heather Beckham
This case study concerns a review and interpretation of test market results for a new packaged good product. The purpose of the case is to provide students with practice and guidelines in the analysis of quantitative test market data while illustrating the roles of... View Details
- October 2017 (Revised July 2018)
- Case
Data Science at Target
By: Srikant M. Datar and Caitlin N. Bowler
Paritosh Desai joined Target.com in 2013 as VP of Business Intelligence, Analytics & Testing to explore how the retailer could use its relatively small but thriving e-commerce arm to drive sales and win customers. The case explores the technological and organizational... View Details
Keywords: Data Science; Analytics and Data Science; Organizational Change and Adaptation; Competitive Strategy; Problems and Challenges; Innovation Leadership
Datar, Srikant M., and Caitlin N. Bowler. "Data Science at Target." Harvard Business School Case 118-016, October 2017. (Revised July 2018.)
- Research Summary
Time-Varying Volatility Risk Premia
This paper provides evidence for the existence of time-varying volatility risk premia. In doing so, it examines the evolution of the implied volatility bias in the S&P 100 from 1986-2006. Additionally, the paper proves three new results regarding the limiting... View Details
- May 2013
- Case
Launching Krispy Natural: Cracking the Product Management Code
By: Frank V. Cespedes and Heather Beckham
Pemberton Products is a U.S. market leader in the cookie and bakery snacks segment of the sweet snack market. Looking to expand into the salty snack market, the company acquires Krispy Inc., a maker of salty snack crackers located in the southeastern U.S. To compete... View Details
Keywords: Analytics and Data Science; Competition; Organizational Culture; Management Teams; Brands and Branding; Expansion; Marketing Strategy; Product Launch; Acquisition; Food and Beverage Industry; Ohio; United States
Cespedes, Frank V., and Heather Beckham. "Launching Krispy Natural: Cracking the Product Management Code." Harvard Business School Brief Case 913-574, May 2013.
- 15 Jun 2020
- Working Paper Summaries
The Seeds of Ideology: Historical Immigration and Political Preferences in the United States
Keywords: by Paola Giuliano and Marco Tabellini
- April 2004 (Revised May 2007)
- Case
Conor Medsystems
By: Donald N. Sull, Robert F. Higgins, Linda A. Cyr and Bijan Salehizadeh
Conor Medsystems had developed a drug-eluting stent that could capture significant share of the $5 billion global market. Chief executive officer, Frank Litvack, is considering alternative sources of financing to test the device. View Details
Keywords: Entrepreneurship; Health Testing and Trials; Corporate Finance; Medical Devices and Supplies Industry
Sull, Donald N., Robert F. Higgins, Linda A. Cyr, and Bijan Salehizadeh. "Conor Medsystems." Harvard Business School Case 804-180, April 2004. (Revised May 2007.)
- February 2024
- Article
Representation and Extrapolation: Evidence from Clinical Trials
By: Marcella Alsan, Maya Durvasula, Harsh Gupta, Joshua Schwartzstein and Heidi L. Williams
This article examines the consequences and causes of low enrollment of Black patients in clinical
trials. We develop a simple model of similarity-based extrapolation that predicts that evidence is
more relevant for decision-making by physicians and patients when it... View Details
Keywords: Representation; Racial Disparity; Health Testing and Trials; Race; Equality and Inequality; Innovation and Invention; Pharmaceutical Industry
Alsan, Marcella, Maya Durvasula, Harsh Gupta, Joshua Schwartzstein, and Heidi L. Williams. "Representation and Extrapolation: Evidence from Clinical Trials." Quarterly Journal of Economics 139, no. 1 (February 2024): 575–635.
- September 2010 (Revised November 2011)
- Case
Salud Digna: Successfully Competing with For-Profit Organizations
By: Allen S. Grossman and Regina Garcia-Cuellar
Hugo Moreno, CEO of Salud Digna, was considering his growth options for the next three years. Would becoming a for-profit with access to greater capital be the best strategy or would this cause the organization to lose its social mission? Salud Digna provided... View Details
Keywords: For-Profit Firms; Health Testing and Trials; Growth and Development Strategy; Corporate Social Responsibility and Impact; Mission and Purpose; Nonprofit Organizations; Health Industry; Mexico
Grossman, Allen S., and Regina Garcia-Cuellar. "Salud Digna: Successfully Competing with For-Profit Organizations." Harvard Business School Case 311-051, September 2010. (Revised November 2011.)
- September 1988
- Case
Vicks Health Care Division: Project Scorpio (D)
Reveals that Vicks chose a multi-condition positioning for the product. Describes testing of name and concept, and extensively reports on a four-city test market. Students are expected to evaluate both the design and results of the test, and face options ranging from... View Details
Kosnik, Thomas J. "Vicks Health Care Division: Project Scorpio (D)." Harvard Business School Case 589-008, September 1988.
- April 2001
- Exercise
Exchange Rate Exercise
Tests students' understanding of exchange rate analytics and how shifts in exchange rates affect firms' economics. View Details
Keywords: Currency Exchange Rate
Kennedy, Robert E. "Exchange Rate Exercise." Harvard Business School Exercise 701-122, April 2001.
- January 2020
- Article
Assessing the Safety of Electronic Health Records: A National Longitudinal Study of Medication-related Decision Support
By: A Jay Holmgren, Zoe Co, Lisa Newmark, Melissa Danforth, David Classen and David Bates
Background Electronic health records (EHR) can improve safety via computerised physician order entry with clinical decision support, designed in part to alert providers and prevent potential adverse drug events at entry and before they reach the patient.... View Details
Keywords: Hospital; Electronic Health Records; Health Care and Treatment; Information Technology; Safety; Performance; Quality; Performance Improvement
Holmgren, A Jay, Zoe Co, Lisa Newmark, Melissa Danforth, David Classen, and David Bates. "Assessing the Safety of Electronic Health Records: A National Longitudinal Study of Medication-related Decision Support." BMJ Quality & Safety 29, no. 1 (January 2020): 52–59.
- July–September 2018
- Article
Memory Bias in Observer-Performance Literature
By: Tamara M. Haygood, Samantha N. Smith and Jia Sun
The objective of our study was to determine how authors of published observer–performance experiments dealt with memory bias in study design. We searched American Journal of Roentgenology online and Radiology using “observer study” and “observer performance.” We... View Details
Haygood, Tamara M., Samantha N. Smith, and Jia Sun. "Memory Bias in Observer-Performance Literature." Art. 031412. Journal of Medical Imaging 5, no. 3 (July–September 2018).
- October 2006 (Revised August 2007)
- Case
Calloway Laboratory: Pee for Profit
By: Richard G. Hamermesh and David Kiron
Describes the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. View Details
Keywords: For-Profit Firms; Health Care and Treatment; Health Testing and Trials; Growth and Development Strategy; Market Entry and Exit; Health Industry
Hamermesh, Richard G., and David Kiron. "Calloway Laboratory: Pee for Profit." Harvard Business School Case 807-040, October 2006. (Revised August 2007.)